Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Hürth

4 clinical trials in Hürth, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Hürth at a glance
4
clinical trials
  • Not yet recruiting0
  • Research sites0
Type of trial
Recruitment status
Quick filters

4 trials in Hürth

Open in trial search

Safety of PF-07872412 versus 20‑valent pneumococcal conjugate vaccine in healthy infants for prevention of pneumococcal disease

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:0–17 years
  • Substances:PF-07831695
  • Sponsor:Pfizer Inc.

Study on the Effectiveness and Safety of a Respiratory Syncytial Virus (RSV) Vaccine in Infants and Toddlers

Investigational
Countries:GermanyGermany
  • Participants:0–17 years · Healthy volunteers
  • Substances:534
  • Sponsor:Sanofi Vaccines US Inc.

Safety and immunogenicity study of Pentavalent Meningococcal ABCYW vaccine (MenPenta SD and MenPenta fHD) compared to licensed meningococcal vaccines in infants, toddlers and children

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:0–17 years · Healthy volunteers
  • Substances:Diphtheria toxoid
  • Sponsor:Sanofi Vaccines US Inc.

Study on the Safety and Immune Response of a 21-Valent Pneumococcal Conjugate Vaccine in Healthy Infants and Toddlers

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:0–17 years · Healthy volunteers
  • Substances:Pneumococcal oligosaccharide serotype 18C conjugated to CRM197
  • Sponsor:Sanofi Vaccines US Inc.

Other cities in Germany

The busiest research cities in the country

All 513 cities in Germany

Clinical research in Hürth

What the registry says about research in the country

01 Infectious Disease Prevention

Research focusing on the development of innovative meningococcal vaccines for children, toddlers, and infants. These trials aim to evaluate safety profiles and immune responses across different age groups.

  • Meningococcal Disease Prevention
  • Pediatric Vaccine Development
  • Immunogenicity Studies

Advanced testing of pentavalent formulations targeting multiple meningococcal strains.

02 Respiratory Disease Research

Clinical investigations centered on a new RSV vaccine designed to prevent lower respiratory tract disease in young children. The research emphasizes efficacy and safety evaluations.

  • Respiratory Syncytial Virus Prevention
  • Pediatric Respiratory Health
  • Vaccine Safety Assessment

Comprehensive evaluation of vaccine effectiveness over complete RSV seasons.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.